Recent University of Sydney Cancer Research Fund grant outcomes
2009
‘Near-miss’ funding for Cancer Institute NSW Research Innovation Grants
Byrne J
Medicine, Children's Hospital Westmead
Increased tumor protein D52 expression as a marker of breast cancer predispoition, and a possible role in DNA repair
$40,000
Dhillon H
Medicine, Central Clinical School
Educating patients about chemotherapy and side-effects: What do nurses say?
$40,000
Mackay J
Science, MMB
Chracterisation of the cancer-related nucleosome remodelling and deacetylese complex
$40,000
Marsh D
Medicine, Kolling Institute, Northern Clinical School
Relationships between miRNA and the phosphatidylinositol 3-kinase/mammamlian target of rapamycin pathway in ovarian cancer
$40,000
Soon P
Medicine, Kolling Institute, Northern Clinical School
The role of microRNAs and EGFR in chemoresistance in breats cancer-associated fibroblasts
$40,000
Vardy J
Medicine, Central Clinical School
Developing an animal model to study the long-term impact of chemotherapy on cognition, mood, pain and general health
$40,000
Winstanley J
Central Clinical School
Improving Quality of Life measurement for melanoma patients: Validity and reliability study of QoL instruments in a NSW population
$40,000
2007
Balleine R
Medicine, Westmead Institute for Cancer Research
Tracing the origin of variable malignant potential in breast cancer
$50,000
Byrne S
Medicine, Central Clinical School
The role of sunlight-induced regulatory B cells in the suppression of anti-tumour immune responses
$99,890
Crosbie J
Health Sciences, Physiotherapy
Impact of mastectomy or breast reconstruction on upper quadrant function following breast cancer
$99,710
Firth S
Medicine, Kolling Institute of Medical Research
Novel interactions of IGFBP-3 with extracullular matrix components: Functional characterisation of the interactions in breast cancer
$100,000
Hammond K
Medicine, Central Clinical School
The role of iNKT cells in ultraviolet radiation-induced immunosuppression
$50,000
Mullan B
Science, Psychology
Brain-body interaction: Randomised control trial of physical activity (medical qigong) for cancer patients
$98,795
Seibel M
Medicine, Anzac Research Institute
Bone and tumour necrosis following anti-resorptive treatment
$89,852
Simanainen U
Medicine, Anzac Research Institute
The role of androgens in prostate physiology and pathology
$100,000
Sutak R
Medicine, Pathology
Molecular examination of the role of iron in oestrogen-dependent and-independent growth of breast cancer cells
$99,995
Thordarson P
Science, Chemistry
Self-assembled hydrogels for local cancer drug delivery
$49,822
Wiley P
Medicine, Nepean Clinical School
Susceptibility to chronic lymphocytic leukemia in an extended family pedigree
$100,000
Young J
Medicine, Surgical Outcomes Research Centre
From theory to practice: Implementing patient decision support tools into everyday clinical practice
$49,350
2006
Dong Q
Medicine, Central Clinical School
Establishment of technical protocols for isolation of prostate stem cells
$48,342
Rose B
Medicine, Central Clinical School
Investigations of microRNAs in Head and Neck Cancer
$49,705
Robinson B
Medicine, Northern Clinical School
Alternative Lengthening of Telomeres and Outcome of Glioblastoma Multiforme
$50,000
Lovejoy D
Medicine, Pathology
The role of the differentiation-related gene-1 (Drg-1) in human prostate cancer metastasis and growth and its potential as a therapeutic target
$50,000
Huxley R
Medicine, Central Clinical School (The George Institute)
Exploration of the impact of smoking and physiological risk factors on cancer mortality in populations of the Asia-Pacific Region
$49,586
Balleine RL
Medicine, Western Clinical School (Westmead Institute for Cancer Research)
Breast cancer subtypes and progesterone receptor isoform expression
$50,000
Kefford RF
Medicine, Western Clinical School (Westmead Institute for Cancer Research)
Tumour suppressive co-operation by the chromatin remodelling factor BRG1 and p16INK4a
$50,000
Sze DMY
Pharmacy
Identification and characterisation of cancer stem cells in myeloma
$50,000
Coster MJ
Science, Chemistry
Synthesis and biological evaluation of new anti-mitotic anti-cancer compounds based on a highly cytotoxic natural product
$49,737
Rendina LM
Science, Chemistry
Tumour specific boronated peptides as a new class of agents for boron neutron capture therapy
$49,885
Todd MH
Science, Chemistry
A New Class of DNA-cleaving Artificial Enzymes
$49,888
Braet FC
Science, Electron Microscope Unit
Apoptosis-inducing anti-actin drugs: a potential approach for suppressing the onset of hepatic metastasis
$38,640
Crossley M
Science, Molecular and Microbial Biosciences
The role of transcription factors in lineage commitment
$49,053
Butow PN
Science, Psychology
Predicting bereavement outcomes in caregivers of women with ovarian cancer
$37,341